HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Backer, C. L. Articles by Mavroudis, C. Search for Related Content PubMed PubMed Citation Articles by Backer, C. L. Articles by Mavroudis, C.

The Journal of Thoracic and Cardiovascular Surgery, Vol 101, 826-832, Copyright © 1991 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association

ARTICLES

Intermediate term results of infant orthotopic cardiac transplantation from two centers

CL Backer, VR Zales, HL Harrison, FS Idriss, DW Benson Jr and C Mavroudis
Division of Cardiovascular-Thoracic Surgery, Children's Memorial Hospital, Chicago, IL 60614.

Orthotopic cardiac transplantation has become established for selected infants with severe forms of congenital heart disease. This study reviews the combined experience and intermediate term results of infants undergoing orthotopic cardiac transplantation from Children's Memorial Hospital, Chicago, and Kosair Children's Hospital, Louisville. From June 1986 through December 1989, 20 orthotopic cardiac transplantations were performed in 19 patients. Sixteen patients had variants of hypoplastic left heart syndrome. One infant had anomalous origin of the left coronary artery with severe ischemic cardiomyopathy. Two infants had aortic stenosis with endocardial fibroelastosis, and one had extracorporeal membrane oxygenation as a bridge to transplantation. Immunosuppression included cyclosporine, azathioprine (Imuran), and corticosteroids with an effort to wean the patients from steroids by 6 months to 2 years. Three early deaths resulted--from technical errors in two patients and from hyperacute rejection in one patient at 3 days. Four late deaths have occurred. Two patients died at 2 and 13 months of acute rejection. One patient died at 15 months of acute rejection after retransplantation. One patient died at 7 months of respiratory syncytial viral pneumonia. The remaining 12 patients are surviving 5 to 47 months (means 20 months) after orthotopic cardiac transplantation. Rejection surveillance in the first 6 months is by clinical signs supplemented by echocardiography, electrocardiography, and cell cycle analysis; endomyocardial biopsy is used after 6 months of age. For the cumulative series, 24 episodes of suspected rejection have been treated during 277 at-risk patient months with intravenous methylprednisolone (Solu-Medrol) (n = 18) and monoclonal antibody (OKT3) (n = 6), for an incidence of 1.04 episodes of rejection per patient per year. Serious posttransplantation infections including endocarditis, catheter sepsis, meningitis, and colonic perforation were successfully treated in four patients. Subjectively, their quality of life is excellent as shown by normal growth and developmental milestones and a low hospital readmission rate (1.4 episodes per patient per year). These encouraging intermediate term results warrant continued application of infant orthotopic cardiac transplantation for severe forms of congenital heart disease.

This article has been cited by other articles:

				C. E. Canter, R. E. Shaddy, D. Bernstein, D. T. Hsu, M. R.K. Chrisant, J. K. Kirklin, K. R. Kanter, R. S.D. Higgins, E. D. Blume, D. N. Rosenthal, et al. Indications for Heart Transplantation in Pediatric Heart Disease: A Scientific Statement From the American Heart Association Council on Cardiovascular Disease in the Young; the Councils on Clinical Cardiology, Cardiovascular Nursing, and Cardiovascular Surgery and Anesthesia; and the Quality of Care and Outcomes Research Interdisciplinary Working Group Circulation, February 6, 2007; 115(5): 658 - 676. [Abstract] [Full Text] [PDF]

				M. Murtra The adventure of cardiac surgery Eur J Cardiothorac Surg, February 1, 2002; 21(2): 167 - 180. [Full Text] [PDF]

				M. B. Mitchell, D. N. Campbell, D. R. Clarke, D. A. Fullerton, F. L. Grover, M. M. Boucek, B. Pietra, M. Luna, A. L. Shroyer, J. R. Coll, et al. Infant heart transplantation: improved intermediate results J. Thorac. Cardiovasc. Surg., August 1, 1998; 116(2): 242 - 246. [Abstract] [Full Text] [PDF]

				C. Canter, D. Naftel, R. Caldwell, R. Chinnock, E. Pahl, E. Frazier, J. Kirklin, M. Boucek, and R. Morrow Survival and Risk Factors for Death After Cardiac Transplantation in Infants : A Multi-institutional Study Circulation, July 1, 1997; 96(1): 227 - 231. [Abstract] [Full Text]

				A. J. Razzouk, R. E. Chinnock, S. R. Gundry, J. K. Johnston, R. L. Larsen, M. F. Baum, N. F. Mulla, and L. L. Bailey Transplantation as a Primary Treatment for Hypoplastic Left Heart Syndrome: Intermediate-Term Results Ann. Thorac. Surg., July 1, 1996; 62(1): 1 - 7. [Abstract] [Full Text]

				P. W. Weldner, J. L. Myers, M. M. Gleason, S. E. Cyran, H. S. Weber, M. G. White, and B. G. Baylen The Norwood operation and subsequent Fontan operation in infants with complex congenital heart disease J. Thorac. Cardiovasc. Surg., April 1, 1995; 109(4): 654 - 662. [Abstract] [Full Text]

				M. D. Iannettoni, E. L. Bove, R. S. Mosca, F. M. Lupinetti, P. C. Dorostkar, A. Ludomirsky, D. C. Crowley, T. J. Kulik, and A. Rosenthal Improving results with first-stage palliation for hypoplastic left heart syndrome J. Thorac. Cardiovasc. Surg., March 1, 1994; 107(3): 934 - 940. [Abstract] [Full Text]